FDA Clears Shock-Absorbing Implant for Refractory Knee OA

(MedPage Today) -- The FDA has authorized marketing of an implantable shock absorber aimed at load reduction for people with refractory knee osteoarthritis (OA) who are not appropriate candidates for arthroplasty, the agency and maker Moximed announced...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news